Report ID: 10210477 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Electronic Drug Delivery Systems Market is valued approximately USD 7.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.7% over the forecast period 2019-2026. Drug delivery includes formulations, technologies, methods and systems for transferring an active pharmaceutical ingredient into the body. Electronic drug delivery systems are an advancement in the field which provides portable, interactive, wirelessly connected delivery systems and support patient administered therapy. The high prevalence of target diseases, the favorable reimbursement scenario in major markets, and advancements in technologies and designs of electronic drug delivery systems has increased the adoption of Electronic Drug Delivery Systems across the globe. However, the operation and functionality issues associated with the electronic devices will act as a restriction to the electronic drug delivery system market.
The regional analysis of global Electronic Drug Delivery Systems market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of target diseases, the favorable reimbursement scenario, and approvals, and launches of innovative electronic drug delivery systems in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing population along with increasing government expenditure on public health and research and development would create lucrative growth prospects for the Electronic Drug Delivery Systems market across Asia-Pacific region.
Major market player included in this report are:
Merck Group (Germany)
Insulet Corporation (US)
Bayer AG (Germany)
Medtronic PLC (Ireland)
Novo Nordisk (Denmark)
United Therapeutics Corporation (US)
Astrazeneca (UK)
Tandem Diabetes Care (US)
Amgen (US)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Electronic Wearable Infusion Pumps
Electronic Autoinjectors
Electronic Injection Pens
Electronic Inhalers
By Indication:
Diabetes
Multiple Sclerosis
Cardiovascular Disease
Asthma & COPD
Other Indications (growth hormone therapy, primary immunodeficiency disease, thalassemia, and Parkinson’s disease)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Electronic Drug Delivery Systems Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investor
C
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10210477 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
